Fortitude Family Office’s Verrica Pharmaceuticals VRCA Stock Holding History

Fortitude Family Office’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$777	Hold	127	–	–	﹤0.01%	1840
2026 Q1	$672	Sell	127 -481	-79%	-$3.08K	﹤0.01%	1620
2025 Q4	$5.05K	Buy	+608	New	+$3.37K	﹤0.01%	806

Other funds holding VRCA

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Fortitude Family Office's VRCA Position: Q2 2026 in Review

Fortitude Family Office held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 127 shares worth $777. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Fortitude Family Office first reported a position in VRCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.05K in Q4 2025. 3 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

Fortitude Family Office held 127 shares of Verrica Pharmaceuticals worth $777 as of Q2 2026.
Fortitude Family Office left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
Verrica Pharmaceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1840 holding.
Fortitude Family Office first reported a position in Verrica Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
Fortitude Family Office's Verrica Pharmaceuticals position peaked at $5.05K in Q4 2025.
3 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.